Robert Langer's Trading History
| SEERSeer | Jul 30, 2026 | Director | Uninformative Buy | ― | $1.38M | |
| MRNAModerna | May 02, 2022 | Director | Uninformative Buy | 100.19K | $2.55B | |
| KRROKorro Bio | Nov 19, 2020 | Director | Uninformative Sell | ― | $3.44M | |
| LYRALyra Therapeutics | May 06, 2020 | Director | Uninformative Buy | ― | $2.88K | |
| OCATOcata Therapeutics | Feb 11, 2016 | ― | Uninformative Sell | 433.50K | $442.56K | |
| BINDQDNIB Unwind, Inc. | Sep 19, 2013 | ― | Uninformative Buy | ― | $104.90K | |
| NVIVQInvivo Therapeutics Holdings | Jun 05, 2013 | ― | Uninformative Sell | 27.95K | $2.75M | |
| ECTEEcho Therapeutics | Apr 30, 2010 | ― | Uninformative Buy | 83.00K | $18.10K | |
| FCSCFibrocell Science | ― | ― | ― | $0.00 | ||
| MNTAMomenta Pharma | ― | ― | ― | $49.86M | ||
| RUBYRubius Therapeutics | ― | ― | ― | $0.00 | ||
| KALAKALA BIO | ― | Director | ― | ― |
You May Also Like
Robert Langer insider profile FAQ
What stocks does Robert Langer hold?
Robert Langer holds: SEER, BINDQ, KALA, RUBY, MRNA, KRRO, LYRA, OCAT, NVIVQ, MNTA, ECTE, FCSC stocks.
What is Robert Langer's role in Seer?
Robert Langer's role in Seer is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.